The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: Review of 98 patients

Journal of Neuro-Oncology

Volumn 80, Issue 1, 2006, Pages 75-82

  Smith, Sarah F ^a   Simpson, Judy M ^b   Brewer, Janice A ^a   Sekhon, Lali H S ^c   Biggs, Michael T ^a   Cook, Raymond J ^a   Little, Nicholas S ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Spine Nevada   (United States)

Author keywords

Glioblastoma; Glioblastomawith oligodendroglial element; Microvascular proliferation; Oligoastrocytoma; Oligodendroglioma; Prognosis; Survival analysis; Tumour grading; Tumour necrosis

Indexed keywords

NERVE GROWTH FACTOR;

ADULT; AGE DISTRIBUTION; ANAPLASTIC OLIGODENDROGLIAL TUMOR; CANCER GRADING; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREDICTION; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TIME SERIES ANALYSIS; TUMOR BIOPSY; TUMOR LOCALIZATION; TUMOR NECROSIS; TUMOR VASCULARIZATION;

AGE FACTORS; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NECROSIS; OLIGODENDROGLIOMA; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 33749177575     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9158-5     Document Type: Review

References (29)

1. He J, Mokhtari K, Sanson M, Marie Y, Kujas M, Huguet S, Leuraud P, Capelle L, Delattre JY, Poirier J, Hoang-Xuan K (2001) Glioblastomas with an oligodendroglial component: A pathological and molecular study. J Neuropathol Exp Neurol 60:9863-9871
2. Perry A (2001) Oligodendroglial neoplasms: Current concepts, misconceptions, and folklore. Adv Anat Pathol 8:4183-4199
3. Cairncross JG, Louis DL(2000): Molecular diagnosis of anaplastic oligodendroglioma subtypes. Neuro-Oncol 254(abstr)
4. Smith SF, Simpson JM, Sekhon L (2005) What progress has been made in surgical management of patients with astrocytoma and oligodendroglioma in Australia over the last two decades? J Clin Neurosci 12:8915-8921
5. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:191473-191479
6. Kleihues P, Cavenee WK (2000) Pathology & Genetics of Tumours of the Nervous System. IARC Press, Lyon
7. Kraus JA, Wenghoefer M, Schmidt MC, von Deimling A, Berweiler U, Roggendorf W, Diete S, Dietzmann K, Muller B, Heuser K, Reifenberger G, Schlegel U (2000) Long-term survival of glioblastoma multiforme: importance of histopathological reevaluation. J Neurol 247:6455-6460
8. Donahue B, Scott CB, Nelson JS, Rotman M, Murray KJ, Nelson DF, Banker FL, Earle JD, Fischbach JA, Asbell SO, Gaspar LE, Markoe AM, Curran W (1997) Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: A report of radiation therapy oncology group 83-02. Int J Radiat Oncol Biol Phys 38:5911-5914
9. Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J, Veelken J, Schramm J, Weller M, Wiestler OD, Louis DN, von DA (2002) Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am J Pathol 161:1313-1319
10. Zlatescu MC, TehraniYazdi A, Sasaki H, Megyesi JF, Betensky RA, Louis DN, Cairncross JG (2001) Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res 61:186713-186715
11. Smith SF, Simpson JM, Sekhon LH (2004) A quarter of a century of neurosurgery: The value of a relational database to document trends in neurosurgical practice of a tertiary referral hospital. J Clin Neurosci 11:131-136
12. Daumas-Duport C, Scheithauer BW, O'Fallon J, Kelly P (1988) Grading of astrocytomas. Cancer 62:2152-2165
13. Microsoft Corporation. Microsoft Office Professional. XP. 2003. Redmond, WA, USA. Ref Type: Computer Program
14. SAS Institute. SAS system for Windows. [v.8.00]. 1999. Cary, NC, USA. Ref Type: Computer Program
15. Scheithauer BW (2004) Oligodendroglioma and 'mixed' oligoastrocytoma. Pathol Int 54(Suppl. 1):S376-S382
16. Daumas-Duport C, Tucker ML, Kolles H, Cervera P, Beuvon F, Varlet P, Udo N, Koziak M, Chodkiewicz JP (1997) Oligodendrogliomas. part II: A new grading system based on morphological and imaging criteria. J Neurooncol 34:161-178
17. Daumas-Duport C, Varlet P, Tucker ML, Beuvon F, Cervera P, Chodkiewicz JP (1997) Oligodendrogliomas. part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: A study of 153 cases. J Neurooncol 34:137-159
18. Giannini C, Scheithauer BW, Weaver AL, Burger PC, Kros JM, Mork S, Graeber MB, Bauserman S, Buckner JC, Burton J, Riepe R, Tazelaar HD, Nascimento AG, Crotty T, Keeney GL, Pernicone P, Altermatt H (2001) Oligodendrogliomas: Reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol 60:3248-3262
19. Mork SJ, Halvorsen TB, Lindegaard KF, Eide GE (1986) Oligodendroglioma. Histologic evaluation and prognosis. J Neuropathol Exp Neurol 45:165-178
20. Smith MT, Ludwig CL, Godfrey AD, Armbrustmacher VW (1983) Grading of oligodendrogliomas. Cancer 52:112107-112114
21. Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T (2002) Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clin Cancer Res 8:1196-1201
22. Kros JM, Troost D, Van Eden CG, van der Werf AJ, Uylings HB (1988) Oligodendroglioma. A comparison of two grading systems. Cancer 61:112251-112259
23. Burger PC, Rawlings CE, Cox EB, McLendon RE, Schold SC, Jr., Bullard DE (1987) Clinicopathologic correlations in the oligodendroglioma. Cancer 59:71345-71352
24. Schiffer D, Bosone I, Dutto A, Di VN, Chio A (1999) The prognostic role of vessel productive changes and vessel density in oligodendroglioma. J Neurooncol 44:99-107
25. Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK (1997) Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79:71381-71393
26. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:3215-3225
27. Kros JM, Van Eden CG, Stefanko SZ, Waayer-Van Batenburg M, van der Kwast TH (1990) Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas. Cancer 66:61204-61212
28. Fortin D, Cairncross GJ, Hammond RR (1999) Oligodendroglioma: An appraisal of recent data pertaining to diagnosis and treatment. Neurosurgery 45:61279-61291
29. Godfraind C, Rousseau E, Ruchoux MM, Scaravilli F, Vikkula M (2003) Tumour necrosis and microvascular proliferation are associated with 9p deletion and CDKN2A alterations in 1p/19q-deleted oligodendrogliomas. Neuropathol Appl Neurobiol 29:5462-5471